Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jan 29;16(1):e0245722.
doi: 10.1371/journal.pone.0245722. eCollection 2021.

Safety of antidepressants in a primary care cohort of adults with obesity and depression

Richard Morriss  1 , Freya Tyrer  2 , Francesco Zaccardi  2 , Kamlesh Khunti  2
Affiliations
Comparative Study

Safety of antidepressants in a primary care cohort of adults with obesity and depression

Richard Morriss et al. PLoS One. .

Abstract

Background: Obesity, depressive disorders and antidepressant drugs are associated with increased mortality, cardiovascular disease, diabetes, fractures and falls. We explored outcomes associated with the most commonly prescribed antidepressants in overweight or obese people with depression.

Methods and findings: We identified a cohort of overweight or obese adults (≥18 years) in primary care from the UK Clinical Practice Research Datalink, linked with hospital and mortality data, between 1 January 2000 and 31 December 2016 who developed incident depression to January 2019. Cox proportional hazards models and 99% confidence intervals were used to estimate hazard ratios (HR) for mortality, cardiovascular disease, diabetes, and falls/fractures associated with exposure to selective serotonin reuptake inhibitors (SSRIs), tricyclic (TCA)/other, combination antidepressants, citalopram, fluoxetine, sertraline, amitriptyline and mirtazapine, adjusting for potential confounding variables. In 519,513 adults, 32,350 (9.2 per 1,000 years) displayed incident depression and 21,436 (66.3%) were prescribed ≥1 antidepressant. Compared with no antidepressants, all antidepressant classes were associated with increased relative risks of cardiovascular disorders [SSRI HR: 1.32 (1.14-1.53), TCA/Other HR: 1.26 (1.01-1.58)], and diabetes (any type) [SSRI HR: 1.28 (1.10-1.49), TCA/Other: 1.52 (1.19-1.94)]. All commonly prescribed antidepressants except citalopram were associated with increased mortality compared with no antidepressants. However, prescription ≥1 year of ≥40mg citalopram was associated with increased mortality and falls/fractures and ≥1 year 100mg sertraline with increased falls/fractures.

Conclusions: In overweight/obese people with depression, antidepressants may be overall and differentially associated with increased risks of some adverse outcomes. Further research is required to exclude indication bias and residual confounding.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Fig 2
Fig 2
Fig 3
Fig 3
See this image and copyright information in PMC

References

    1. World Health Organisation: Obesity Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 24/10/2019.
    1. Kelly T, Yang W, Chen CS, Reynolds K, He J: Global burden of obesity in 2005 and projections to 2030. Int J Obesity (2005) 2008, 32:1431–37. 10.1038/ijo.2008.102 - DOI - PubMed
    1. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. : Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67:220–229. 10.1001/archgenpsychiatry.2010.2 - DOI - PubMed
    1. Tyrer F, Zaccardi F, Khunti K, Morriss R. Incidence of depression and first-line antidepressant therapy in people with obesity and depression in primary care. Obesity 2020;28:977–984. 10.1002/oby.22772 - DOI - PubMed
    1. Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol 2018;6:944–953. 10.1016/S2213-8587(18)30288-2 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances